Search for: "Eli Lilly " Results 1201 - 1220 of 2,131
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Jul 2011, 1:35 am by Dr. Stuart Baran
  In Human Genome Sciences Inc v Eli Lilly and Company [2010] EWCA Civ 33, all of these questions had to be considered before evaluating the validity of a patent owned by Human Genome Sciences (“HGS”). [read post]
17 Jul 2011, 9:55 am by Hugh Tomlinson QC, Matrix Law
There are two appeals in the Supreme Court beginning with Human Genome Sciences Inc v Eli Lilly and Company to be heard on Monday 18 to Wednesday 20 July 2011 by Lords Hope, Walker, Neuberger, Collins and Clarke. [read post]
15 Jul 2011, 1:15 pm
Indianapolis, IN - Patent lawyers for Eli Lilly Company of Indianapolis, Indiana filed a patent infringement judgment suit in the Southern District of Indiana alleging APP Pharmaceuticals LLC of Schaumburg, Illinois infringed patent no.7,772,209 , Antifolate combination therapies, which has been issued by the US Patent Office. [read post]
12 Jul 2011, 7:20 am by Broc Romanek
At Eli Lilly, the company failed in its fifth consecutive effort to receive the requisite more than 80% outstanding shares in support. [read post]
12 Jul 2011, 6:59 am by randal shaheen
The Southern District of California did an about-face after granting a TRO, and denied a preliminary injunction to stop Eli Lilly & Co from using the same 700-person sales force to market rival drugs. [read post]
8 Jul 2011, 11:04 am by Bexis
June 23, 2011), the industry is trying again for clarity in the morass that is the FDA’s current regulation (if it can be called that) of off-label promotion.Earlier this week, seven large drug/device manufacturers (Allergan, Eli Lilly, J&J, Novartis, Novo Nordisk, and Sanofi-Aventis) filed a Citizen Petition with the FDA demanding that the Agency replace its current mish-mash of non-binding guidance documents, letters, press releases, criminal plea agreements, and just… [read post]
6 Jul 2011, 2:21 am by Marie Louise
One District Court has an answer: Nycomed v Tolmar (FDA Law Blog) Trizivir (Abacavir) – US: ViiV Healthcare files patent infringement complaint against Lupin in response to Para IV certification filing (Patent Docs) Welchol (Colesevelam) – US: Glenmarks settles litigation with Daiichi Sankyo, Genzyme (GenericsWeb) Xeloda (Capecitabine) – US: Hoffman-La Roche files patent infringement suits against Accord Healthcare, Teva and Roxane following Para IV certification filing (Patent… [read post]
5 Jul 2011, 7:07 am by Stefanie Levine
Here is the latest installment of Reexamination Requests from Scott Daniels, of Reexamination Alert and Practice Center Contributor… A10 Networks may have set a record last week when it requested reexamination of 13 Brocade patents involving global servers (see ex parte Request Nos. (2)-(3), (5)-(8), (11)-(17)). [read post]
5 Jul 2011, 7:07 am by Stefanie Levine
Here is the latest installment of Reexamination Requests from Scott Daniels, of Reexamination Alert and Practice Center Contributor… A10 Networks may have set a record last week when it requested reexamination of 13 Brocade patents involving global servers (see ex parte Request Nos. (2)-(3), (5)-(8), (11)-(17)). [read post]
24 Jun 2011, 11:19 pm by Apeng
(FDA Law Blog) Europe seizure of generic drugs: Lilly settles with Indian generics / Eli Lilly???????????? [read post]
24 Jun 2011, 3:25 pm by Christa Culver
This edition of “Petitions to watch” features cases up for consideration at the Justices’ June 23 Conference. [read post]
23 Jun 2011, 6:33 pm by Frank Pasquale
AstraZeneca marketed Seroquel off-label for children and the elderly (another vulnerable population, often administered antipsychotics in nursing homes); Pfizer faced similar charges for Geodon (an antipsychotic); Eli Lilly for Zyprexa (an antipsychotic); Bristol-Myers Squibb for Abilify (another antipsychotic); and Forest Labs for Celexa (an antidepressant). [read post]